Understanding how specific proteins in the eye lens interact with cell membranes as we age.
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
This study is looking at how a special protein called alphaA-crystallin interacts with lens cells in our eyes, especially as we age and develop cataracts, to help find ways to prevent or slow down cataract formation.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Albany NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10833663 on NIH RePORTER |
What this research studies
This research investigates the interactions of alphaA-crystallin, a protein crucial for maintaining lens transparency, with the membranes of lens cells. It focuses on how aging and cataract formation affect these interactions, which may lead to lens opacity. By examining the binding of alphaA-crystallin to unique membrane components, the study aims to uncover the molecular mechanisms that contribute to age-related cataracts. This could provide insights into potential therapeutic strategies to delay or prevent cataract development.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults who are at risk of developing cataracts or have early signs of cataract formation.
Not a fit: Patients with cataracts unrelated to aging or those who have already undergone cataract surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help maintain lens transparency and prevent cataracts in aging individuals.
How similar studies have performed: Previous research has shown promising results in understanding protein interactions in the lens, but this specific approach focusing on alphaA-crystallin and its modifications is relatively novel.
Where this research is happening
Albany, United States
- State University of New York at Albany — Albany, United States (Active)
Researchers
- Principal investigator: Pande, Jayanti — State University of New York at Albany
- Study coordinator: Pande, Jayanti
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.